Evolv Technologies Board Member Gets Significant Stock Award as Company Growth Continues

Rhea-AI Filing Summary

Evolv Technologies Holdings (EVLV) reported a Form 4 filing disclosing an insider transaction by Director David Mounts Gonzales on June 20, 2025. The director was granted 27,050 Restricted Stock Units (RSUs) as part of the company's equity compensation plan.

Key details of the RSU grant:

• Each RSU represents a right to receive one share of Class A common stock
• The RSUs were granted at $0 cost to the director
• Vesting will occur in full at the earlier of June 20, 2026 or the day before the next annual meeting
• The RSUs have no expiration date

This transaction appears to be part of standard director compensation arrangements. The filing was signed by Rachel Roy as attorney-in-fact for David Mounts Gonzales on June 24, 2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mounts Gonzales David

(Last) (First) (Middle)

C/O EVOLV TECHNOLOGIES HOLDINGS, INC.

500 TOTTEN POND ROAD, 4TH FLOOR

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Evolv Technologies Holdings, Inc. [ EVLV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	06/20/2025		A		27,050		(2)	(1)	Class A Common Stock	27,050	$0	27,050	D

Explanation of Responses:

1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date.

2. The RSUs will vest in full at the earlier of June 20, 2026 or the day immediately preceding the Issuer's next annual meeting date.

Remarks:

	/s/ Rachel Roy, Attorney-in-fact for David Mounts Gonzales	06/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Restricted Stock Units (RSUs) did EVLV director David Mounts Gonzales receive on June 20, 2025?

According to the Form 4 filing, EVLV director David Mounts Gonzales received 27,050 Restricted Stock Units (RSUs) on June 20, 2025. Each RSU represents a contingent right to receive one share of EVLV's Class A common stock.

When will David Mounts Gonzales' EVLV RSUs vest?

The RSUs will vest in full at the earlier of two dates: June 20, 2026, or the day immediately preceding EVLV's next annual meeting date.

What was the exercise price of EVLV RSUs granted to David Mounts Gonzales?

The RSUs were granted at $0 cost to David Mounts Gonzales, as indicated in the Form 4 filing under the 'Price of Derivative Security' column.

Who filed this Form 4 for EVLV director David Mounts Gonzales?

The Form 4 was signed by Rachel Roy, serving as Attorney-in-fact for David Mounts Gonzales, on June 24, 2025.

What is David Mounts Gonzales' role at EVLV?

According to the Form 4 filing, David Mounts Gonzales serves as a Director of Evolv Technologies Holdings, Inc. (EVLV), as indicated by the 'X' marked in the Director box under the Relationship of Reporting Person(s) to Issuer section.